Dear user,

Thank you for your interest in the Access Accelerated Open Platform. We are proud to reveal that we have upgraded our platform to an improved system to offer you a new and superior user experience. The data on the old platform will not be updated any longer.

Please visit our new AA Open Platform

Current Filters (0)

No Filters

TOTAL RESOURCES: 1203

No. of resources: 1204

Our Research Efforts

Visit / Download

Topics : COVID-19

Keywords : BMS / COVID 19 / R&D / Public health

Year :

Increasing access to radiotherapy in low and middle income countries: resources for the cities

Visit / Download

Topics : Cancer

Year :

Reframing Non-Communicable Diseases and Injuries for Equity in the Era of Universal Health Coverage: Findings and Recommendations from the Kenya NCDI Poverty Commission

Visit / Download

Region : Africa

Year :

People at the center: PHC at PATH

Visit / Download

Year :

World Bank Support for Country Access to COVID-19 Vaccines

Visit / Download

COVID-19 Response

Topics : COVID-19

Keywords : World bank / COVID-19 / Accessibility / Vaccine

Year :

Guidance on operational microplanning for COVID-19 vaccination

Visit / Download

Topics : COVID-19

Keywords : Vaccination / Vaccine / COVID-19 / Recommendations / Guidelines

Year :

Daiichi Sankyo Financial Results for the First Six Months of 2021

Visit / Download

Keywords : Daiichi Sankyo / Finance / Healthcare / Strategy / Analysis

Year :

Using Digital Health Solutions to Transform Cancer Care at Scale

Visit / Download

Topics : Cancer

Year :

Samoa Returns to Community-based Approach to Contain Rise of Non-Communicable Diseases

Visit / Download

Region : Western Pacific

Topics : Cancer / Cardiovascular Diseases / Diabetes / Respiratory Diseases / Others

Keywords : Cancer / Cardiovascular Diseases / Diabetes / Others / Respiratory Diseases

Year :

Source :

Eli Lilly signs licensing pact with Cipla, Sun, Lupin for Covid-19 drug

Visit / Download

COVID-19 Update

Topics : COVID-19

Keywords : Eli Lilly and Company / R&D / Vaccine / COVID-19

Year :

Pages

TERMS OF USE

IFPMA (“we”, “us”) owns and operates www.ifpma.org (“the/our website”). Any person accessing and/or using the website (“the visitor/user”) agrees to the “Terms of Use”, containing the conditions, rules and other provisions with respect to the access and/or use of our website. If you have questions about the “Terms of Use”, please feel free to contact us at admin@ifpma.org.

CONTENT

GENERAL USE

The material contained on this website is for information only. The website is entitled to be served as an information resource for the internal and external stakeholders of IFPMA, including the general public. Third-Party Websites Links to other websites are provided solely as a convenience and therefore imply neither IFPMA’s responsibility for, nor its approval of the information contained in these websites. Intellectual Property Any use of information from the website should have an acknowledgement of IFPMA/Third-Party as a source respectively, citing the corresponding uniform resource locator (URL). Logo and Name The use of IFPMA’s name and/or logo is prohibited without prior express authorization from IFPMA. The access and/or use of the website does not permit to copy, reproduce, modify, distribute or elsehow exploit IFPMA’s name and/or logo except with the prior explicit permission. Abuse and Violation Any abuse or violations of the Terms of Use and/or Privacy Policy should be reported to admin@ifpma.org.

PRIVACY POLICY

IFPMA is committed to protecting the privacy and security of visitors to our website. Outlined below is our online privacy policy for information collected through our website. If you have questions about these policies, please feel free to contact us at admin@ifpma.org.

USE OF COOKIES FILES

Our website is enhanced by cookie files to personalize and customize the experience of our visitors and to support some necessary functions. IFPMA collects broad usage statistics using Google Analytics, to better understand how our visitors use our website, and to help us improve visitors’ experience. Such information includes the IP address (where available), browser type, and any additional information provided by a browser during the use of our website. The statistical data about our users’ browsing actions and patterns does not identify any individual. You may choose to accept or refuse cookies by modifying your browser preferences. If you wish to get notified when a cookies are set, this option should also be available in your browser settings. Please note that if you reject some or all cookies, your experience at this and other websites throughout the Internet may not be complete.

PAYMENT TRANSACTIONS

To enable IFPMA to process any order or registration to an event, a secure online payment system may be used to process payments using credit card details. IFPMA will not be collecting or storing credit card details in our system.

THIRD-PARTY WEBSITES

Please be aware that other websites to which links may be provided, including social media, may collect visitor’s personally identifiable information when accessed. The information collection practices of other websites linked to IFPMA’s website are not covered by this Privacy Policy.

Top bar

The Access Accelerated logo, as well as the home icon will bring you back to the landing page. Additionally you can get some help, find information about the data approach, settings as well as the walk-through, whenever available.
Search and Filtering

You can either look for a specific file by searching for a name or key word, or by using the provided filters. The reset button let you start from the beginning.
Results

Your filter or search result will be shown in then middle area.
Sort resources

You can sort the resources either alphabetically or by recently added.
Other useful areas

These buttons will show you the glossary, all collected NCDs policies or other useful links.
NCDs Chart and Taxonomy Density

Both of these areas visualize the density and amount of recourses that were collected for the respective indicator.